Research To Practice | Oncology Videos: First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor (Companion Faculty Lecture)

First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor (Companion Faculty Lecture)

Apr 9, 2025

Featuring a slide presentation and related discussion from Dr Justin F Gainor, including the following topics:

Duration of responses observed with ALK inhibitors in patients with ALK-positive metastatic non-small cell lung cancer (mNSCLC) (0:00)
Current role of other systemic therapy options for the treatment of ALK-positive mNSCLC; management of oligometastatic disease (8:38)
Local therapy approaches for treating CNS disease in ALK-positive mNSCLC (18:32)
Tolerability profile of lorlatinib (23:28)
Review of clinical investigator survey results (37:08)
Novel ALK inhibitors under clinical development (53:31)